[Do growth-promoting hormones have an effect on dentition development in dwarfism?]

Area of Science:

• Pediatric Endocrinology
• Orthodontics
• Growth and Development

Background:

• Nanism in children presents diagnostic challenges, with distinctions between hypophyseal ateleiosis, constitutional delayed development, and familial ateleiosis.
• Somatotropic hormone (human growth hormone) is the primary regulator of linear growth.
• Understanding growth patterns is crucial for effective pediatric interventions.

Purpose of the Study:

• To explore the efficacy of somatotropic hormone and anabolic agents in stimulating growth in children with specific types of nanism.
• To investigate the impact of these growth-stimulating treatments on bone maturation and dentition development.
• To determine optimal timing for orthodontic interventions based on growth acceleration and skeletal age.

Main Methods:

• Review of clinical cases involving children diagnosed with various forms of nanism.
• Analysis of growth patterns and bone maturation following administration of human growth hormone and anabolic steroids.
• Correlation of treatment effects with dental development and skeletal age assessments.

Main Results:

• Human growth hormone effectively stimulates growth and accelerates bone maturation in hypophyseal ateleiosis and constitutional delayed development.
• Anabolic agents also promote growth, with a notable acceleration in bone maturation and dental development.
• Treatment-induced growth spurts provide critical windows for orthodontic interventions.

Conclusions:

• Somatotropic hormone and anabolic agents are valuable therapeutic options for managing growth deficits in pediatric nanism.
• These treatments significantly influence skeletal and dental maturation, necessitating careful consideration for orthodontic planning.
• Optimizing orthodontic treatment during periods of accelerated growth, guided by skeletal age, maximizes therapeutic outcomes.